Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
[Correction] Notice Concerning Revisions to Notice Concerning Revisions to the Financial Results Forecasts and Dividend Forecasts (No dividends) and P
TAKARA BIO, Ordinary Profit Forecast for the Fiscal Year Revised Downward to a Loss, Dividend Dividend Also Turns into No Dividend
Notice Concerning Revisions to the Financial Results Forecasts and Dividend Forecasts (No dividends) and Partial Return of Executive Remuneration
Consolidated Financial Results for the Six Months Ended September 30, 2025
Notice Concerning Revisions to Financial Results Forecasts for the First Half, Recognition of Extraordinary Loss, and Reversal of Deferred Tax Assets
TAKARA BIO, Net Income Forecast for First Half Loss Widened in Downward Revision
Consolidated Financial Results for the Three Months Ended June 30, 2025 (Under Japanese GAAP)
Consolidated Financial Results for the Three Months Ended June 30, 2025 (Under Japanese GAAP)
TAKARA BIO, Apr-Jun (1Q) Ordinary Profit Loss Widens
Consolidated Financial Results for the Three Months Ended June 30, 2025 (Under Japanese GAAP)
Consolidated Financial Results for the Three Months Ended June 30, 2025 (Under Japanese GAAP)
Matters Concerning Controlling Shareholders
Notice Concerning Dividend from Surplus
Notice of Changes in Representative Directors
Notice of Changes in Representative Directors
Notice of Changes in Representative Directors
Notice of Changes in Representative Directors
Notice of Changes in Representative Directors
Notice Concerning Dividend from Surplus
Notice of Changes in Representative Directors